Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.613, 2010-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
DPP-IV inhibitors could be cost-effective for T2DM
Inpharma, Vol. 1, Iss. 1642, 2008-01 ,pp. :
Access to resources
Recommend
DPP-IV inhibitors could be cost-effective for T2DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 556, 2008-01 ,pp. :
Exenatide effective adjuvant to thiazolidinedione therapy for T2DM
Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. :
Omalizumab effective add-on therapy in INNOVATE study
Inpharma, Vol. 1, Iss. 1486, 2005-01 ,pp. :
Add-on insulin glargine enhances HRQOL in type 2 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. :